NBS – NeoStem, Inc.

NBS: Vanquishes Disease Through Stem Cell Therapy

Cardiovascular disease costs over $445 billion today and is projected to grow to $1 trillion by 2030 according to the American Heart Association. Stem cell research aims to make a significant and positive impact on this number one killer in America. NeoStem Inc. (NBS) is a stem cell company taking a multi-pronged approach to stem cell research and is on track to be the huge winner in the coming stem cell age.

NBS is involved in the manufacture of cell therapy-based treatments. It also provides contract development and manufacturing services to other members of the regenerative medicine field, including adult stem cell collection and storage services.

 

34 thoughts on “NBS – NeoStem, Inc.

  1. Pingback: pic5678
  2. Pingback: hote industriale
  3. Pingback: ruay
  4. Pingback: som777
  5. Pingback: โคมไฟ
  6. Pingback: exchange crypto
  7. Pingback: Bundle extractor
  8. Pingback: wps office
  9. Pingback: poker online
  10. Pingback: hit789
  11. Pingback: faw99
  12. Pingback: Michael
  13. Pingback: 홀덤사이트

Comments are closed.